Abstract
The frequency and the significance of apocrine differentiation in carcinomas of the breast are uncertain, because of the lack of reliable and reproducible criteria for morphological diagnosis. The 15 kDa glycoprotein of cystic breast disease (GCDFP-15) is regarded as a specific functional marker of apocrine cells. Expression of the prolactin-inducible protein (PIP)/GCDFP-15 gene was investigated by Northern blot analysis and in situ hybridization in breast cancer cell lines and in an unselected series (33 cases) of primary carcinomas of the breast. On the same cases, histological assessment of apocrine differentiation and immunocytochemical detection of GCDFP-15 were also performed and correlated with follow-up data. The presence of PIP/GCDFP-15 mRNA was a feature of a relatively high number of cases, but was incompletely correlated with histological and immunocytochemical evidences of apocrine differentiation. Expression of the PIP/GCDFP-15 gene was significantly associated with relapse-free survival, and may represent a novel variable of functional and prognostic relevance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abati AD, Kimmel M, Rosen PP (1990) Apocrine mammary carcinoma. A clinicopathologic study of 72 cases. Am J Clin Pathol 94:371–377
Armitage P, Berry G (1987) Statistical methods in medical research, 2nd edn, Blackwell, Oxford
Azzopardi JG (1979) Problems in breast pathology. Major problems in pathology series, vol II, W. B. Saunders, Philadelphia, pp. 57–67, 341–344
Bloom HJC, Richardson WW (1957) Histological grading and prognosis in breast cancer: a study of 1,409 cases of which 359 have been followed for 15 years. Br J Cancer 11:359–377
Bundred NJ, Stewart HJ, Shaw DA, Forrest APM, Miller WR (1990) Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Eur J Cancer 26:1145–1147
Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ (1979) Isolation of biologically active RNA from sources enriched in ribonuclease. Biochemistry 18:5294–5297
Eusebi V, Betts C, Haagensen DE, Gugliotta P, Bussolati G, Azzopardi JC (1984) Apocrine differentiation in lobular carcinoma of the breast. A morphological, immunologic and ultrastructural study. Hum Pathol 15:134–140
Eusebi V, Millis RR, Cattani MG, Bussolati G, Azzopardi JG (1986) Apocrine carcinoma of breast. Am J Pathol 123:532–541
Eusebi V, Magalhaes F, Azzopardi JG (1992) Pleomorphic lobular carcinoma of the breast. Hum Pathol 23:655–662
Fisher ER, Gregorio RM, Fisher B (1975) The pathology of invasive breast cancer. Cancer 36:1–78
Frable WJ, Kay S (1968) Carcinoma of the breast: histologic and clinical features of apocrine tumors. Cancer 21:756–763
Haagensen D. E. (1991) Is cystic disease related to breast cancer? Am J Surg Pathol 15:687–694
Haagensen DE Jr, Mazoujian G, Dilley WG, Pedersen CE, Kister SJ, Wells SA Jr (1979) Breast gross cystic disease fluid analysis. Isolation and radioimmunoassay for a major component protein. J Natl Cancer Inst 62:239–247
Haagensen CD, Bodian C, Haagensen DE Jr. (1981) Breast carcinoma: risk and detection. W. B. Saunders, Philadelphia
Hsu SM, Raine L, Fanger H (1981) The use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase technique. J Histochem Cytochem 29:577–580
Kazumaki M, More IAK, Cochran AJ, Klein G (1980) Thirteen new mammary tumor cell lines from different mouse strains. Eur J Cancer 16:1181–1192
Klimpfinger M, Zisser G, Ruhri C, Putz B, Steindorfer P, Höfler H (1990) Expression of c-myc and c-fos mRNA in colorectal carcinoma in man. Virchows Arch [B] 59:165–171
LeDoussal V, Zangerle PF, Collette J, Spyratos F, Hacene K, Briere M, Franchimont P, Gest J (1985) Immunohistochemistry of a component protein of the breast cystic disease fluid of mol wt 15,000. Eur J Cancer Clin Oncol 21:715–725
Mazoujian G, Pinkus GS, Davis S, Haagensen DE (1983) Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. Am J Pathol 110:105–112
Mazuojian G, Bodian C, Haagensen DE Jr, Haagensen CD (1989) Expression of GCDFP-15 in breast carcinomas: relationship to pathological and clinical factors. Cancer 63:2156–2161
Mossler JA, Barton TK, Brinkhous AD, McCarty KS, Moylan JA, McCarty JS (1980) Apocrine differentiation in human mammary carcinoma. Cancer 46:2463–2471
Murphy LC, Lee-Wing M, Goldenberg GJ, Shiu RPC (1987) Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res 47:4160–4164
Murphy LC, Murphy LJ, Tsuyuki D, Dukworth MI, Shiu RP (1988) Cloning and characterization of cDNA encoding a highly conserved, putative calcium binding protein, identified by an anti-prolactin receptor antiserum. J Biol Chem 263:2397–2401
Myal Y, Gregory C, Wang H, Hamerton JL, Shiu RP (1989) The gene for prolactin-inducible protein (PIP), uniquely expressed in exocrine organs, maps to chromosome 7. Somat Cell Mol Genet 15:265–270
Myal Y, Robinson DB, Iwasiow B, Tsuyuki D, Wong P, Shiu RP (1991) The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation. Mol Cell Endocrinol 80:165–175
Pagani A, Papotti M, Winkler H, Höfler H, Bussolati G (1990) Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot and hybridization analyses. Am J Pathol 136:319–327
Pagani A, Eusebi V, Bussolati G (1994) Detection of PIP/GCDFP-15 gene expression in apocrine epithelium of the breast and salivary glands. Appl Immunohistochem 2:29–35
Page DL, Anderson TJ, Sakamoto J (1987) Infiltrating lobular carcinoma. In: Page DL, Anderson TJ (eds) Diagnostic histopatology of the breast. Churchill Livingstone, New York, pp. 219–226
Rosen PP, Oberman H (1993) Tumors of the mammary gland. Atlas of tumor pathology. Third series. Armed Forces Institute of Pathology, Washington DC, fascicle 7
Sapino A, Papotti M, Sanfilippo B, Gugliotta P, Bussolati G (1992) Tumor types derived from epithelial and myoepithelial cell lines of R3230AC rat mammary carcinoma. Cancer Res 52:1553–1560
SAS Institute. (1985) SAS user's guide: statistical version. 5th edn, SAS Institute, Cary, NC
Shiu R, Myal Y, Robinson D, Iwasow B, Yarmill A, Watson P (1992) The prolactin-inducibile protein/gross cystic disease fluid protein (PIP/GCDFP-15): genetic analysis and hormonal regulation of gene expression. In: Dogliotti L, Sapino A, Bussolati G (eds) Breast cancer: biological and clinical progress. Kluwer Academic, Boston, pp. 93–101
Sugimoto T, Ueyama H, Hosoi H, Inazawa J, Kato T, Kemshead JT, Reynolds CP, Gown AM, Mine H, Sawada T (1991) Human neuroblastoma cell lines expressing alpha-smooth actin and desmin. Int J Cancer 48:277–283
Wich MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel C, Klang DT (1989) Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 20:281–287
Author information
Authors and Affiliations
Additional information
Work supported by grants from Associazione Italiana per la Ricerca ca sul Cancro (AIRC) (Milan, Italy), Consiglio Nazionale Ricerche (CNR, grant N. 93.02125.PF39), Ministero dell' Universita' e della Ricerca Scientifica e Tecnologica (MURST), Rome, Italy.
Rights and permissions
About this article
Cite this article
Pagani, A., Sapino, A., Bergnolo, P. et al. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Vichows Archiv A Pathol Anat 425, 459–465 (1994). https://doi.org/10.1007/BF00197548
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00197548